Showing results (11-20 of 1,054) with videos related to
Sort By:
Pageof 106
Alzheimer'S & Dementia (New York, N. Y.)|February 7, 2022
The impact of pimavanserin on psychotic phenotypes and tau phosphorylation in the P301L/COMT- and rTg(P301L)4510 mouse models of Alzheimer's diseaseHeidy Jimenez, Leslie Adrien, Adam Wolin, et al.Alzheimer'S & Dementia (New York, N. Y.)|February 7, 2022
The efficacy of mindfulness-based cognitive therapy to improve depression symptoms and quality of life in individuals with memory difficulties and caregivers: A short reportLana J Ozen, Sacha Dubois, Megan M English, et al.Alzheimer'S & Dementia (New York, N. Y.)|October 25, 2021
Predicting future amyloid biomarkers in dementia patients with machine learning to improve clinical trial patient selectionFabian H Reith, Elizabeth C Mormino, Greg ZaharchukAlzheimer'S & Dementia (New York, N. Y.)|February 10, 2022
Erratum:Alzheimer'S & Dementia (New York, N. Y.)|June 14, 2019
The protective effects of polyphenols on Alzheimer's disease: A systematic reviewChiara ColizziAlzheimer'S & Dementia (New York, N. Y.)|June 15, 2019
Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims dataYi Chen, Bryan Tysinger, Eileen Crimmins, et al.Alzheimer'S & Dementia (New York, N. Y.)|June 19, 2019
The Alzheimer's Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer's diseaseCristina Lopez Lopez, Pierre N Tariot, Angelika Caputo, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
Early Alzheimer's disease-like reductions in gray matter and cognitive function with aging in nonhuman primatesBrett M Frye, Suzanne Craft, Thomas C Register, et al.Alzheimer'S & Dementia (New York, N. Y.)|March 21, 2022
Secular trends in prevalent mild cognitive impairment: Data from the Swedish population-based study Good Aging in SkåneMarieclaire Overton, Mats Pihlsgård, Sölve ElmståhlAlzheimer'S & Dementia (New York, N. Y.)|September 29, 2021
Preventing Alzheimer's disease within reach by 2025: Targeted-risk-AD-prevention (TRAP) strategyFrancesca Vitali, Gregory L Branigan, Roberta Diaz BrintonPageof 106